Register
Community
Overview
Experts
Editors
Fellows
Code of conduct
AI Guidelines for Physicians
Company
About Us
FAQs
Privacy Policy
Terms of Use
Careers
Programs
News
News Releases
Press Coverage
Publications
Blog
Contact Us
Sign in
Please select the option that best describes you:
Topics:
Medical Oncology
•
Hematology
•
Benign Hematology
How do you treat an adult with Diamond-Blackfan anemia that is steroid refractory, transfusion dependent, and not a candidate for transplant?
Related Questions
Do you use direct oral anticoagulants to treat port-a-cath related VTE in patients with an active malignancy?
How would you treat suspected secondary HLH in patients whom etoposide is contraindicated?
Would you anticoagulate an SMV thrombosis caused by malignant obstruction in the setting of metastatic colorectal cancer?
How do you counsel sickle cell patients on the use of G-CSF to treat neutropenia from other causes, like malignancy?
Would you consider a positive DAT and indirect Coombs test, persistent and consistent with IgG warm antibody, clinically significant in absence of hemolysis?
In which cases would you consider early transition to DOAC (within 72 hours) for hospitalized patients with intermediate or high risk PE?
How do you time CSF analysis for suspected CNS lymphoma in patients who are on steroids?
How is your experience with point-of-care INR systems for home monitoring of vitamin K antagonists?
What screening tools or signs do you use to predict if a cancer patient is near end-of-life?
Would you evaluate for thrombophilia in patients with incidental splenic infarcts in the setting of known cirrhosis, portal hypertension, and splenomegaly?
